跳至主要内容
临床试验/NCT00245700
NCT00245700已完成不适用

Study of Adherence of Stalevo, Entacapone and Levodopa

South Glasgow University Hospitals NHS Trust1 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2005年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
14
试验地点
1

研究概览

简要总结

To test if combining two antiparkinson drugs into a single tablet improves accuracy of medicine intake by the patient.

To test if patients with Parkinson's disease who take medicines at regular time intervals have smoother symptom control.

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with Parkinson's disease aged between 18 and 85 years fulfilling UK Brain Bank criteria.
  • Current levodopa therapy prescribed on a regular basis three or more times per day but requiring entacapone because of 'wearing off'
  • Able to manipulate electronic monitoring bottles and complete questionnaires

排除标准

  • Current use of compliance aid such that study participation would be detrimental to patient's adherence
  • Pregnancy or breast feeding
  • Excess alcohol (over 21 units per week for women and 28 units for men)
  • Mini mental state examination of less than
  • Severe depression (Geriatric depression score over 20)

研究者

发起方
South Glasgow University Hospitals NHS Trust
申办方类型
Other

研究点 (1)

Loading locations...

相似试验